Skip to content

Research at St Andrews

Allosteric inhibition of cobalt binding to albumin by fatty acids: Implications for the detection of myocardial ischemia

Research output: Contribution to journalArticle

DOI

Author(s)

Jin Lu, Alan J. Stewart, Peter J. Sadler, Teresa J. T. Pinheiro, Claudia A. Blindauer

School/Research organisations

Abstract

The biomarker "Ischemia-Modified Albumin" (IMA), measured by the albumin-cobalt binding assay (ACB assay), is the only FDA-approved biomarker for early diagnosis of myocardial ischemia. Based on the hypothesis that high levels of free fatty acids are directly responsible for reduction in cobalt binding by albumin, chemically defined model systems consisting of BSA, Co2+, and myristate were studied by Isothermal Titration Calorimetry, 111Cd NMR spectroscopy, and ACB assays. Significantly reduced Co2+ binding to albumin, as demonstrated by an increase in absorption of the Co-dithiothreitol adduct, elicited by adding ca. 3 molar equivalents of myristate was comparable to that observed in clinical ACB assays. Levels of free fatty acids are elevated during myocardial ischemia, but
also in other conditions that have been correlated with high IMA values. Hence, IMA may correspond to albumin with increased levels of bound fatty acids, and all clinical observations can be rationalised by this molecular mechanism.
Close

Details

Original languageEnglish
Pages (from-to)4425-4430
Number of pages6
JournalJournal of Medicinal Chemistry
Volume55
Issue number9
Early online date23 Apr 2012
DOIs
Publication statusPublished - 10 May 2012

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Reduced plasma magnesium levels in type-1 diabetes associate with prothrombotic changes in fibrin clotting and fibrinolysis

    Sobczak, A. I. S., Phoenix, F. A., Pitt, S. J., Ajjan, R. A. & Stewart, A. J., 11 Nov 2019, (Accepted/In press) In : Thrombosis and Haemostasis.

    Research output: Contribution to journalArticle

  2. A metalloproteomic analysis of interactions between plasma proteins and zinc: elevated fatty acid levels affect zinc distribution

    Coverdale, J. P. C., Barnett, J. P., Adamu, A. H., Griffiths, E. J., Stewart, A. J. & Blindauer, C. A., 15 Oct 2019, In : Metallomics. Advance Article, p. 1-15 15 p.

    Research output: Contribution to journalArticle

  3. Plasma non-esterified fatty acids contribute to increased coagulability in type-2 diabetes through altered plasma zinc speciation

    Sobczak, A. I. S., Katundu, K. G. H., Phoenix, F. A., Khazaipoul, S., Yu, R., Lampiao, F., Stefanowicz, F., Blindauer, C. A., Pitt, S. J., Smith, T. K., Ajjan, R. A. & Stewart, A. J., 28 Aug 2019, In : biorxiv. 38 p.

    Research output: Contribution to journalArticle

  4. Changes in plasma free fatty acids associated with type-2 diabetes

    Sobczak, A. I. S., Blindauer, C. A. & Stewart, A. J., 28 Aug 2019, In : Nutrients. 11, 9, 42 p., 2022.

    Research output: Contribution to journalReview article

  5. Sub-micromolar pulse dipolar EPR spectroscopy reveals increasing CuII-labelling of double-histidine motifs with lower temperature

    Wort, J. L., Ackermann, K., Giannoulis, A., Stewart, A. J., Norman, D. G. & Bode, B. E., 19 Aug 2019, In : Angewandte Chemie - International Edition. 58, 34, p. 11681-11685 5 p.

    Research output: Contribution to journalArticle

Related by journal

  1. Journal of Medicinal Chemistry (Journal)

    Terry K Smith (Member of editorial board)
    2013 → …

    Activity: Publication peer-review and editorial work typesPeer review of manuscripts

Related by journal

  1. Discovery of trifluoromethyl glycol carbamates as potent and selective covalent monoacylglycerol lipase (MAGL) inhibitors for treatment of neuroinflammation

    McAllister, L., Butler, C., Mente, S., O'Neil, S. V., Fonseca, K., Piro, J., Cianfrogna, J., Foley, T., Gilbert, A., Harris, A., Helal, C. J., Johnson, D. S., Montgomery, J. I., Nason, D. M., Noell, S., Pandit, J., Rogers, B. N., Samad, T. A., Shaffer, C. L., da Silva, R. G. & 3 others, Uccello, D. P., Webb, D. & Brodney, M. A., 12 Apr 2018, In : Journal of Medicinal Chemistry. 61, 7, p. 3008–3026

    Research output: Contribution to journalArticle

  2. Emergence of small molecule non-RGD-mimetic inhibitors for RGD integrins

    Miller, L. M., Pritchard, J. M., Macdonald, S. J. F., Jamieson, C. & Watson, A. J. B., 30 Jan 2017, In : Journal of Medicinal Chemistry. 60, 8, p. 3241-3251

    Research output: Contribution to journalArticle

  3. Rational design of autotaxin inhibitors by structural evolution of endogenous modulators

    Keune, W-J., Potjewyd, F., Heidebrecht, T., Salgado-Polo, F., Macdonald, S. J. F., Chelvarajan, L., Abdel Latif, A., Soman, S., Morris, A. J., Watson, A. J. B., Jamieson, C. & Perrakis, A., 9 Mar 2017, In : Journal of Medicinal Chemistry. 60, 5, p. 2006-2017 12 p.

    Research output: Contribution to journalArticle

  4. Structure-activity relationships of small molecule autotaxin inhibitors with a discrete binding mode

    Miller, L. M., Keune, W-J., Castagna, D., Young, L. C., Duffy, E. L., Potjewyd, F., Salgado-Polo, F., Garcia, P. E., Semaan, D., Pritchard, J. M., Perrakis, A., Macdonald, S. J. F., Jamieson, C. & Watson, A. J. B., 26 Jan 2017, In : Journal of Medicinal Chemistry. 60, 2, p. 722-748 27 p.

    Research output: Contribution to journalArticle

  5. Establishment of a structure-activity relationship of the 1H-imidazo[4,5-c]quinoline-based kinase inhibitor NVP-BEZ235 as a lead for African sleeping sickness

    Seixas, J. D., Luengo-Arratta, S. A., Diaz, R., Saldivia, M., Rojas-Barros, D. I., Manzano, P., Gonzalez, S., Berlanga, M., Smith, T. K., Navarro, M. & Pollastri, M. P., 12 Jun 2014, In : Journal of Medicinal Chemistry. 57, 11, p. 4834-4848 15 p.

    Research output: Contribution to journalArticle

ID: 19660904

Top